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Abstract  
Background 
Accurate assessment of surgical site infection (SSI) is crucial for surveillance and 
research. Self-report patient measures are needed because current SSI tools are 
limited for assessing patients after leaving hospital. The Bluebelle Wound Healing 
Questionnaire (WHQ) was developed for patient or observer completion and this 
study tested its acceptability, scale structure, reliability and validity in patients with 
closed primary wounds after abdominal surgery. 
Methods 
Patients completed the WHQ (self-assessment) within 30 days after leaving hospital 
and returned it by post. Healthcare professionals (HCPs) completed the WHQ 
(observer assessment) by telephone or face-to-face. Questionnaire response rates 
and patient acceptability were assessed. Factor analysis and Cronbach’s alpha 
examined scale structure and internal consistency. Test-retest and self- versus 
observer reliability assessments were performed. Sensitivity and specificity for SSI 
discrimination against a face-to-face reference diagnosis (using Centres for Disease 
Control and Prevention (CDC) criteria) was examined.  
Results 
591/792 (70.8%) self-assessments and 597/791 (74.4%) observer assessments 
were completed with few missing data and problems reported. Data supported a 
single scale structure with strong internal consistency (alpha >0.8). Reliability 
between test-retest and self- versus observer assessments was good (kappa > 0.6 
for the majority of items). Sensitivity and specificity for SSI discrimination was high 
(area under the receiver operating characteristic (ROC) curve=0.9056). 
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Conclusions 
The Bluebelle WHQ is acceptable, reliable and valid with a single scale structure for 
post-discharge patient or observer assessment of SSI in closed primary wounds. It is 
now ready for use in trials and routine practice.  
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INTRODUCTION  
Surgical site infection (SSI) is the third most common healthcare-associated infection 
(HCAI) in the UK[1] influencing patient outcomes, quality of life and healthcare 
resources[2]. Rates of SSI vary considerably, depending in part on the type of surgery 
performed (e.g. clean or contaminated) and individual patient risk factors. Many SSIs 
can take time to become apparent, often developing or becoming symptomatic after 
the patient has left hospital[3, 4] . Rate estimates are also influenced by methods and 
timing of data collection, particularly the robustness of post-discharge follow-up[2, 5, 6]. 
Accurate assessment after discharge is therefore key to SSI surveillance and 
research to minimise this important healthcare issue[7]. 
 
Assessing wounds for SSI after hospital discharge can be done by patient self-
report, by asking patients to return for an outpatient appointment or by conducting 
home visits. The latter two methods are resource intensive[8]. Patient self-report can 
reduce these burdens, although accurate tools are needed. Existing post-discharge 
self-report questionnaires for patients[9-11] have methodological weaknesses. They 
have been adapted from tools intended for professional completion, lack patient 
input in their development, have not been validated for use in a post-discharge 
setting, and have been criticised because they do not account for symptom severity; 
an important aspect in SSI diagnosis[12]. The Bluebelle Wound Healing 
Questionnaire (WHQ) was developed with input from patients and multi-disciplinary 
healthcare professionals to address these limitations. It assesses signs, symptoms 
and wound care interventions relevant for the diagnosis of SSI in closed primary 
wounds specifically after the patient has left hospital[13]. Early work has 
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demonstrated that the WHQ is comprehensive, easily understood and can be 
completed by patients and/or observers (healthcare professionals)[13]. The current 
study examined the acceptability, scale structure, reliability and validity of the WHQ 
in a large sample of patients undergoing surgery with closed primary abdominal 
wounds.  
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METHODS  
 
The Bluebelle Wound Healing Questionnaire (WHQ) 
The WHQ was developed as part of the Bluebelle study[14], a feasibility study 
including a pilot RCT to examine whether a randomised controlled trial (RCT) of 
different wound dressing strategies for reducing SSI was possible[14, 15]. Initial 
development of the WHQ has been previously reported[13]. The WHQ was designed 
as a single questionnaire for patient and/or observer completion. The version of the 
questionnaire undergoing validation in this study consisted of 16 items; eight relating 
to signs and symptoms of SSI and eight relating to wound care interventions. Two of 
these items included additional components, collecting more detail on signs and 
symptoms, if applicable. The early versions of the questionnaire also included 
questions on resource use (for the wider Bluebelle feasibility study) and were not 
relevant to SSI diagnosis, therefore are not included in these analyses. Response 
categories for sign and symptom items were “not at all=0”, “a little=1”, “quite a bit=2” 
and “a lot=3”. Response categories for wound care intervention items were “yes=1”, 
“no=0”, or “don’t know”. Higher scores, therefore, indicated more problems. 
 
Study design  
Two datasets from the Bluebelle study were used in this analysis: i) data from a 
cohort recruited specifically to validate this new measure, and, ii) data from the pilot 
RCT. Research ethics approval was granted from the NHS Health Research 
Authority NRES Committee London – Camden & Kings Cross (reference 
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14/LO/0640) and the South West – Frenchay Research Ethics Committee (reference 
15/SW/0008).  
 
Eligible participants were aged over 16, undergoing elective or unplanned abdominal 
general surgery or caesarean section. Excluded were participants who lacked 
capacity, ability to read or understand English and prisoners. Further inclusion and 
exclusion criteria were relevant to the wider requirements of the Bluebelle study and 
have previously been reported[14]. Studies ran between August 2015 and January 
2016, and March 2016 and November 2016 (cohort study and pilot RCT, 
respectively) from four UK NHS hospital trusts. Participants were recruited by 
research nurses, surgical trainees or other trained members of the study team on 
hospital wards pre- or post-surgery. Potential participants were given a participant 
information leaflet and were provided with sufficient time to consider involvement and 
discuss the study before being re-approached to take part. All participants were 
asked to give written informed consent.  
 
Data collection  
Figure 1 illustrates the study design and data collection.  
WHQ self-assessment 
The WHQ was distributed by post for participants to complete and return (by 
stamped addressed envelope, included) 30 days after surgery. Instructions were to 
complete the WHQ in relation to events since hospital discharge. A subset of cohort 
participants (n=50, sampled during one month of the study) were posted an 
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additional WHQ within a week of completing the first WHQ (for test-retest 
assessment). In a series of debriefing questions included with the WHQ, data were 
collected from the cohort participants on the time needed for WHQ completion, 
whether help was required, and whether items were confusing or difficult to answer. 
Reminders for non-responders were sent only to participants in the pilot RCT.  
 
WHQ observer assessment 
In the cohort study, the WHQ was completed by a clinical member of the study team 
via a telephone call with participants four to five weeks after surgery. In the pilot 
RCT, the WHQ was completed by a clinical member of the study team during the 
participant’s face-to-face follow-up appointment between four and eight weeks after 
surgery.  
  
Reference diagnoses of whether SSI had occurred since the time of surgery were 
made in face-to-face study follow-up appointments between four and eight weeks 
after surgery using the CDC criteria and classification of no SSI, superficial, deep or 
organ/space[16]. Diagnoses were made by an independent member of the study 
team, blinded to the WHQ self- and observer assessment, using any available 
sources of information from the participant and hospital records. All pilot RCT 
participants and a convenience sample of cohort participants (sampled by availability 
due to limited study resources) underwent a face-to-face reference wound 
assessment.  
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Socio-demographic, clinical and operative details were collected directly from the 
participant or from hospital records. All data were collected on paper copy forms and 
entered onto a secure, study-specific electronic database. 
 
Analyses  
All 16 items were included in the initial analysis. Missing responses to the items with 
multiple components (collecting more detail on signs and symptoms, if applicable) 
were imputed with values of 0 if no response was expected (for example, if the 
sign/symptom had not occurred). Summation of item scores and application of any 
weightings was performed as suggested by the data. Reference SSI diagnoses 
using the CDC criteria were dichotomised to create a binary variable with 0= “no SSI” 
and 1= “SSI of any type” (combining CDC classifications of superficial, deep and 
organ/space SSI due to low numbers of reported deep and organ/space SSI).  
 
i) Acceptability  
Acceptability of the WHQ was explored in three ways. First, by examining response 
rates (i.e. the proportion of completed WHQ self- and observer assessments). 
Second, by exploring missing responses to individual items (indicating possible 
issues such as not understanding the item). Third, by examining answers to the 
debriefing questions.  
 
ii) Scale structure  
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Exploratory factor analyses examined the underlying structure and constructs of the 
questionnaire. Analyses were conducted separately for self- and observer data. First, 
correlations of all iterations of item pairs were explored using a correlation matrix of 
Pearson’s correlation coefficients. Pairs with very high item-item correlations (r=0.9 
or above) were examined for similarity and considered for redundancy and exclusion 
prior to conducting factor analyses[17]. Next, three separate factor analysis models 
were run using the maximum-likelihood (ml) method of estimation specifying the 
maximum number of factors to be retained as one, two and three factors in three 
separate models (maximum-likelihood method of estimation). Eigenvalues and item 
factor loadings were examined to explore the suitability of the fit of each model to the 
data. Models were initially explored with data from the cohort study and the best 
fitting model was applied to data from the pilot RCT as a method of independent 
validation of the scale structure. The best fitting model was finally applied to the 
combined cohort and pilot RCT data to demonstrate its fit to the full dataset. Due to 
the ordinal, categorical nature of the WHQ data and violation of the assumption of 
normality of the data, A sensitivity factor analysis was performed using a polychoric 
matrix due to the ordinal, categorical nature of the WHQ data ,and compared with 
analyses using the traditional correlation matrix[18]. Multi-trait scaling analyses were 
also applied as a comparative statistical approach[19]. 
Internal consistency (internal reliability) of the scales identified from the factor 
analyses was examined using Cronbach’s alpha coefficient as a measure of the 
extent that items in each scale measure the same construct[17]. Values greater than 
0.7 were considered to have good internal consistency[17].  
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iii) Reliability 
Test-retest reliability [20] was assessed to establish if the WHQ was free from 
measurement error by comparing self-assessment responses to the WHQ completed 
twice over a period of anticipated stable health. Stable health was assumed if 
responders had reported that they had not been back into hospital for treatment with 
a problem with the wound (item 11) in the retest assessment. Cross-tabulations of 
test-retest responses and weighted kappa statistics were calculated. Equal weights 
between response categories for ordinal items (items 1-8) were assumed, with 
weighted values of 0, 0.333, 0.667 and 1 between categories. Kappa values <0.4 
were considered to indicate poor agreement. Values between 0.4 and 0.75 were 
considered to indicate fair to good agreement[17]. 
 
Inter-rater reliability (agreement between self- and observer assessments, where 
data from both assessments were available) was explored, to examine the reliability 
of the self-assessment for collecting outcome data in a future large-scale trial. Cross-
tabulations of item responses for each item and weighted kappa statistics were 
calculated as described above. Percentages of agreement and discordance were 
examined.  
 
 
iv) Validity 
Criterion validity was examined against the reference CDC SSI diagnosis to 
demonstrate how well the WHQ performed in discriminating between individuals with 
and without SSI. Cross-tabulations of the binary variable of the reference CDC 
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diagnosis (‘no SSI’ or ‘SSI of any type’) and a binary variable of the self-assessment 
WHQ total score (created by a cut-off score (e.g. WHQ total score < x and WHQ total 
score >x) were compared. Sensitivity and specificity values for different WHQ cut-off 
scores were calculated from these frequencies. Sensitivity and 1-specificity values of 
the WHQ for each of the different cut-off scores were used to plot a receiver 
operating characteristic (ROC) curve, representing the trade-off between sensitivity 
and specificity[21]. The overall ability of the WHQ to discriminate between individuals 
with and without SSI was measured by the c-statistic: the area under the ROC curve 
(AUC) and 95% confidence intervals. An AUC value approaching 1.0 was interpreted 
to indicate good discrimination with high sensitivity and specificity whereas a value of 
0.5 was interpreted as the measure not being able to discriminate at all[21]. 
 
Analyses were performed using STATA statistical software version 14[22]. 
 
Modifications for the final questionnaire  
Findings from the above were used to inform modifications to the final version of the 
WHQ considering rates of missing data for individual items, answers to the 
debriefing questions and overlap between items (if correlations r>0.9 were 
observed).   
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RESULTS  
 
Data from 792 participants were examined (Figure 1). Table 1 presents participant 
socio-demographic, clinical and operative details. Median times between surgery 
and participant self- and observer WHQ assessments were 29 days (inter-quartile 
range 24 to 33 days) and 37 days (inter-quartile range 32 to 48 days) respectively. 
Most responses recorded little or no SSI signs or symptoms (Supplementary Table 
S1). 
 
i) Acceptability  
Response rates  
Self- and observer WHQ assessments were completed for 561/792 (70.8%) and 
597/791 (75.5%) participants, respectively, with 470/791 (59.4%) of these 
participants having both sets of data completed. In total, 104/792 (13.1%) of 
participants did not have a WHQ self-assessment or an observer assessment 
available at all (complete non-responders). 
 
Missing responses to items 
Less than 3% of responses were missing for most (10/16) items in the self-
assessments and no items had more than 4% of responses missing (Supplementary 
Table S1). In observer assessments, nearly all (15/16) items had less than 2% of 
responses missing. Missing responses to the additional components of the two items 
where further information on signs and symptoms were intended to be collected (if 
applicable) were, however, high, with up to 43% of self-assessments missing a 
Page 14 of 51
http://mc.manuscriptcentral.com/bjs
BJS
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
FOR REVIEW
 ONLY
15 
 
response when one would have been expected. Missing responses to these 
additional components were lower in the observer assessments, although levels 
were still notable and ranged between 8% and 17% (Supplementary Table S1).  
 
Responses to debriefing questions 
Most participants (276/302; 91%) reported that the questionnaire took less than 10 
minutes to fill in. Less than 6% reported needing help or finding items difficult or 
confusing to answer.  
 
ii) Scale structure  
A high correlation (r=0.95) was observed between item 4 (“Have the edges of any 
part of the wound separated/gaped open on their own accord? (spontaneous 
dehiscence))” and its additional component collecting further information; 4a (“Did 
the skin separate?”). Study team agreement of similarity in the underlying concept of 
these questions deemed part 4a redundant and was therefore excluded from factor 
analyses.  
Factor analyses of the cohort and pilot RCT data separately supported a single scale 
structure. Results from the combined dataset are shown in Table 2. Item factor 
loadings ranged between 0.32 and 0.87 in data from participant self-assessments 
and between 0.33 and 0.85 in data from observer assessments (with the exception 
of one item with a factor loading=0.03). Examination of eigenvalues and factor 
loadings provided little evidence to suggest a better fit for a two or three factor model 
(Supplementary Tables S3a and S3b). Sensitivity analyses using a polychoric 
correlation matrix supported findings for a single scale model. A comparative multi-
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trait scaling analysis approach also demonstrated strong association of items to a 
single scale.  
Data suggested it was sensible to calculate a WHQ total score by summating the 
raw scores for each item without any weightings. 
Cronbach’s alpha for a single scale was high, with coefficients of 0.86 in participant 
data and 0.88 in observer data. 
 
 
iii) Reliability 
Test-retest reliability 
In total 44/50 (88.0%) participants included in the test-retest sample (who all 
reported stable health) completed and returned a second WHQ. The median time 
between test-retest assessments was five days (inter-quartile range four to seven 
days). Agreement in responses for test-retest assessments was high with levels of 
observed agreement greater than 86.2% for all items (Supplementary Table S2). 
Where it was possible to calculate a reliable kappa statistic, the majority of values 
were greater than 0.59. 
 
Inter-rater reliability  
Self- and observer assessments were available for 470/791 (59.4%) participants, 
with a median of eight (inter-quartile range two to 16) days between assessments. 
Agreement was generally high (observed agreement for any item >84.3%), although 
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participants showed a trend to report levels of signs and symptoms to be slightly 
more severe than observers (example from one item is shown in Figure 2; see 
Supplementary Figure 2 for data from all items). Where it was possible to calculate a 
reliable kappa statistic, values were between 0.4 and 0.74 for the majority of items 
(Supplementary Table S3). Some minor discrepancy was shown between participant 
and observer responses to wound care intervention items, and whether these 
interventions had occurred. For example, six self-reports of wound reopening were 
not reported in observer assessments and eight observer reports of wound 
reopening were not reported by participants (Supplementary Table S6).  
 
iv) Validity 
Reference SSI diagnoses (face-to-face, using CDC critera) were available for 
417/791 (52.7%) participants. Analysis showed that the sensitivity and specificity of 
the WHQ self-assessment for discriminating SSI/no SSI was high with an area under 
the ROC curve of 0.906 (95% confidence interval 0.83 to 0.98) (Figure 3). A cross-
tabulation of self-assessment WHQ total score (excluding item 4a) against the 
reference SSI diagnosis is provided in Supplementary Table S4. Sensitivity and 
specificity values for selected WHQ cut-off scores are shown in Supplementary 
Table S5. In the current dataset, a cut-off score around the region of 6 to 8 
demonstrated to be a reasonable threshold for suggesting no SSI/SSI compared to 
the reference diagnosis, with relatively few misclassifications (Supplementary Table 
S7). 
 
Modifications for the final questionnaire  
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Evidence supported the need for minor revisions to the WHQ format to improve its 
efficiency and minimise missing data. Item 3 and its additional components collecting 
more information (3a-c) were restructured into three ‘standalone’ items. Item 4a was 
removed. Items were renumbered to accommodate these changes. Response 
options of ‘don’t know’ were removed. Questions collecting resource use purely for 
the purposes of the economic analysis of the Bluebelle pilot RCT were no longer 
included. The final WHQ items, following these revisions, are presented in Table 3. 
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DISCUSSION    
This study examined the acceptability, scale structure, reliability and validity of the 
WHQ for use as a patient or observer-completed tool for the assessment of SSI in 
closed primary surgical wounds after abdominal surgery. The WHQ was found to be 
acceptable to patients, and demonstrated good response rates with low levels of 
missing data. Analyses supported a single scale structure to assess SSI that made 
clinical and practical sense. Test-retest reliability was high and agreement between 
participants and observers was good. The WHQ demonstrated high sensitivity and 
specificity for SSI discrimination compared to a face-to-face reference CDC 
diagnosis. It is therefore suggested that the WHQ is an acceptable, reliable and valid 
patient-reported or observer-completed questionnaire to assess SSI in closed 
primary surgical wounds.  
 
Existing self-reported questionnaires for patients have mostly been adapted from the 
CDC criteria and ASEPSIS tools[11, 16, 23]. They are limited because of the lack of user 
involvement in development. Criticisms include that they are complicated and difficult 
to complete[11, 24]. These self-report measures are also limited by poor design, such 
as asking for yes/no responses to questions without the option to report the ‘amount’ 
or ‘severity’ of the sign/symptom. This is important when assessing a wound, 
demonstrated, for example, in a recent study which found that the amount of exudate 
was more strongly associated with SSI than the type of exudate[12]. Existing patient 
measures, however, do not provide an opportunity for the amount of exudate to be 
captured. The same study also highlighted that bright red skin was observed in 
patients who had SSI but also in patients that did not, providing another example 
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where capturing the ‘amount’ or ‘severity’ of a sign/symptom rather than just its 
presence or absence is important. The WHQ has addressed these limitations by 
involving a multidisciplinary team (including patients, surgeons, nurses, 
microbiologists and health service researchers) in its development and by using a 
combination of qualitative and quantitative methods and it has undergone rigorous 
pre-testing during its development to ensure face and content validity [13].  The result 
is a reliable, valid, comprehensive and uncomplicated questionnaire that, to improve 
on existing tools, includes an ordinal response scale to capture symptom severity.  
 
To the authors’ knowledge, this is the first study to formally assess and validate an 
SSI assessment tool that can be completed by patients as well as healthcare 
professionals, including an evaluation of the psychometric properties. The authors 
also believe it is the first study to demonstrate reliability of self-assessment for 
collecting SSI data, and to provide evidence that SSI can be measured as a single 
construct showing coherence of items assessing SSI signs and symptoms and 
wound care interventions on the same scale. Further strengths of this study are the 
large number of participants and the wide range of types of abdominal operations.  
However, the study has some limitations. Firstly, a true ‘gold standard’ for SSI 
diagnosis without subjective perceptions or opinions is lacking, meaning tests for 
criterion validity are limited. The CDC classification for SSI diagnosis was chosen as 
the best available reference standard for comparing the WHQ as it is the most 
commonly used and widely regarded tool available in the absence of any other 
suitable criterion. Secondly, reports of the more ‘major’ wound care interventions 
(such as debridement and drainage) were rare in this dataset, which may have an 
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impact, for example, on factor analyses. In addition, some discrepancy was 
observed between participant and observer reports of these ‘major’ interventions, 
suggesting possible low fidelity of participant responses. Although these more ‘major’ 
interventions were rare in this dataset and the number of discordant reports between 
self- and observer assessments were few, this discrepancy may be an important 
observation to consider and warrants further investigation to explore this more 
thoroughly as it may have implications for studies relying solely on patient self-
assessment for collecting outcome data. Missing data in responses to the additional 
component parts of items collecting further information on signs and symptoms (if 
applicable) were relatively high, however, may be explained by the layout of the 
questionnaire and modifications in the revised version aim to address this. Although 
the wide range of abdominal operations is a strength of this study, it is recognised 
that the proportion of participants undergoing caesarean section (12.3%) is likely to 
have affected the representative age of the rest of the sample presenting for general 
abdominal surgery and may have affected the findings. Finally, other limitations of 
this work relate to its testing and use after abdominal surgery alone, and for wounds 
healing by primary intention.  
 
Further use and validation of the final version of the WHQ in other types of wounds 
and surgical specialties is underway. Cut-off scores for SSI diagnosis will be 
explored. In addition, members of the research group are also exploring the 
feasibility of collecting digital images of the wound taken by patients as a tool to use 
in conjunction with the WHQ for improving remote and blinded SSI assessment. 
Advances in digital technology, including the use of smart phones and other tablet 
devices with cameras, mean that obtaining data from patients post-discharge is 
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becoming increasing more accessible. Other groups in the field of SSI are exploring 
the development and use of mobile phone applications (apps) specific for monitoring 
wounds [25, 26]. These moves towards using digital technologies to obtain patient-
reported data, including images of wounds, have great potential for improving SSI 
assessment and ultimately patient care. 
 
In summary, this study shows that the WHQ is acceptable, reliable and valid for use 
for post-discharge assessment of closed primary wounds after abdominal surgery. It 
is recommended for use as an outcome measure in trials and in routine surveillance.  
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Pilot RCT 
Recruited: n=394 
Cohort study 
Recruited: n=416 
Surgery  
Socio-demographic data  
Operation details  
 
Withdrawals: n=15 
Reference SSI diagnosis  
4-8 weeks after surgery (face to face) 
 
 
 
 
WHQ observer assessment  
4-5 weeks after surgery  
(by telephone) 
WHQ observer assessment  
4-8 weeks after surgery 
(face to face) 
Figure 1. Participants and data contributing to the validation of the Wound Healing 
Questionnaire (WHQ). 
 
  
 
 
 
Total participants included in analysis n=792 
 
Available data: 
WHQ self-assessment n=561 
WHQ observer assessment n=597 
Self and observer assessment n=470 
Reference SSI diagnosis n=417 
 
Withdrawals: n=1 
Withdrawals: n=2 
WHQ participant self-assessment 
30 days after surgery 
 
Debriefing questionnaire  
 
Test-retest WHQ self-assessment  
Within 1 week of 1
st
 assessment  
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Table 1. Baseline sociodemographic, clinical and operative details of the study 
sample  
 
*percentages are the proportion available data (excluding missing values) 
ASA: American Society of Anesthesiologists, BMI: body mass index  
 
Characteristic N=792 Missing (n) 
Age, years, mean (SD) 53.3 (17.5) 0 
Male sex, n (%) 370 (46.1) 0 
Duration of surgery, n (%)   40 
Less than 1 hour 215 (28.2)  
1 to 2 hours 183 (24.0)  
2 to 3 hours 139 (18.2)  
More than 3 hours 225 (29.5)  
Type of operation, n (%)  12 
Caesarean section 97 (12.3)  
Oesophagogastric resection / gastrectomy  19 (2.4)  
Pancreaticobiliary resection  38 (4.8)  
Anti-reflux surgery  12 (1.5)  
Bariatric surgery  6 (0.8)  
Cholecystectomy 102 (12.9)  
Colectomy/hemicolectomy 99 (12.5)  
Hartmann’s procedure / reversal 21 (2.7)  
Rectal/anterior resection  73 (9.2)  
Stoma formation alone  11 (1.4)  
Stoma closure/reversal alone  19 (2.4)  
Small bowel resection 39 (4.9)  
Groin hernia repair 61 (7.7)  
Abdominal wall hernia repair 37 (4.7)  
Appendicectomy 57 (7.2)  
Diagnostic laparoscopy / laparotomy 31 (3.9)  
Adhesiolysis 12 (1.5)  
Other 56 (7.1)  
Type of surgery, n (%)  48 
Elective  613 (81.3)  
Unplanned 141 (18.7)  
Risk factor   
Smoking, n (%)  16 
current 116 (14.8)  
Ex <1 month 239 (30.4)  
No 431 (54.8)  
Diabetes, any type, n (%) 63 (8.0) 17 
ASA score, n (%)  61 
I 232 (31.3)  
II 381 (51.4)  
III 120 (16.2)  
IV 8 (1.1)  
BMI, mean (SD) 28.0 (6.0) 30 
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Table 2. Factor analysis for a single scale structure* 
 Self-
assessment 
(n=362) 
Observer 
assessment 
(n=501) 
Eigenvalue 5.26 5.08 
Item   
1 Was there redness spreading away from 
the wound? (erythema/cellulitis) 
0.45 0.66 
2 Was the area around the wound warmer 
than the surrounding skin? 
0.32 0.56 
3 Was any part of the wound leaking fluid? 0.87 0.85 
3a Was it clear fluid? (serous exudate) 0.57 0.45 
3b Was it blood-stained fluid? 
(haemoserous exudate) 
0.72 0.58 
3c Was it thick and yellow/green fluid 
(pus/purulent exudate) 
0.57 0.64 
4 Have the edges of any part of the wound 
separated/gaped open on their own 
accord? (spontaneous dehiscence) 
0.66 0.63 
4b Did the deeper tissue separate? 0.59 0.43 
5 Has the area around the wound become 
swollen? 
0.32 0.36 
6 Has the wound been smelly? 0.49 0.43 
7 Has the wound been painful to touch? 0.36 0.37 
8 Have you had, or felt like you have had, 
a raised temperature or fever? (fever 
>38oC) 
0.39 0.39 
9 Have you sought advice because of a 
problem with your wound, other than at a 
routine planned follow-up appointment? 
0.61 0.59 
10 Has anything been put on the skin to 
cover the wound? (dressing) 
0.42 0.54 
11 Have you been back into hospital for 
treatment with a problem with your 
wound? 
0.45 0.35 
12 Have you been given antibiotics for a 
problem with you wound? 
0.65 0.67 
13 Have the edges of your wound been 
deliberately separated by a doctor or 
nurse? 
0.41 0.40 
14 Has your wound been scraped or cut to 
remove any unwanted tissue? 
(debridement of wound) 
0.34 0.03 
15 Has your wound been drained? 
(drainage of pus/abscess) 
0.38 0.33 
16† Have you had an operation under 
general anaesthetic for treatment of a 
problem with your wound? 
- - 
*Using combined cohort and pilot RCT data 
† Model dropped this item because of collinearity 
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Figure 2. Comparison of responses in self- and observer assessments for the first 
item in the WHQ.  
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Figure 3. Receiver operating characteristic (ROC) curve for WHQ self-assessment 
total score for discriminating SSI compared to the reference diagnosis 
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Table 3: Revised WHQ items after analyses 
 Item Response categories 
1 Was there redness spreading away from the wound? 
(erythema/cellulitis) 
Not at all / A little / Quite a bit / A lot 
2 Was the area around the wound warmer than the surrounding 
skin? 
Not at all / A little / Quite a bit / A lot 
3 Has any part of the wound leaked clear fluid? (serous exudate) Not at all / A little / Quite a bit / A lot 
4 Has any part of the wound leaked blood-stained fluid? 
(haemoserous exudate) 
Not at all / A little / Quite a bit / A lot 
5 Has any part of the wound leaked thick and yellow/green fluid 
(pus/purulent exudate) 
Not at all / A little / Quite a bit / A lot 
6i) Have the edges of any part of the wound separated/gaped 
open on their own accord? (spontaneous dehiscence) 
Not at all / A little / Quite a bit / A lot 
6ii) Did the deeper tissue separate? Not at all / A little / Quite a bit / A lot 
7 Has the area around the wound become swollen? Not at all / A little / Quite a bit / A lot 
8 Has the wound been smelly? Not at all / A little / Quite a bit / A lot 
9 Has the wound been painful to touch? Not at all / A little / Quite a bit / A lot 
10 Have you had, or felt like you have had, a raised temperature 
or fever? (fever >38oC) 
Not at all / A little / Quite a bit / A lot 
11 Have you sought advice because of a problem with your 
wound, other than at a routine planned follow-up appointment? 
Yes / No 
12 Has anything been put on the skin to cover the wound? 
(dressing) 
Yes / No 
13 Have you been back into hospital for treatment with a problem 
with your wound? 
Yes / No 
14 Have you been given antibiotics for a problem with you 
wound? 
Yes / No  
15 Have the edges of your wound been deliberately separated by 
a doctor or nurse? 
Yes / No  
16 Has your wound been scraped or cut to remove any unwanted 
tissue? (debridement of wound) 
Yes / No  
17 Has your wound been drained? (drainage of pus/abscess) Yes / No  
18 Have you had an operation under general anaesthetic for 
treatment of a problem with your wound? 
Yes / No  
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Supplementary Figure 1. Comparison of responses to items in self- and observer 
assessments, for participants with data from both assessments (n=470) 
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Supplementary Table S1. Distribution of responses and missing data for each item in participant self-assessments (n=561) and 
observer assessments (n=597) 
  Distribution of responses
**
 
 Missing response* Not at all A little Quite a bit A lot 
Item n (%) n (%) n (%) n (%) n (%) 
1 
Was there redness spreading away from the wound? 
(erythema/cellulitis) 
  
 
 Participant self-assessments  8 (1.4) 314  (56.8) 192 (34.7) 36 (6.5) 11 (2.0) 
 Observer assessments 1 (0.2) 416 (69.8) 130 (21.8) 33 (5.5) 17 (2.9) 
2 
Was the area around the wound warmer than the surrounding 
skin? 
  
 
 Participant self-assessments 19 (3.4) 312 (57.6) 189 (34.9) 32 (5.9) 9 (1.7) 
 Observer assessments 1 (0.2) 444 (74.5) 108 (18.1) 34 (5.7) 10 (1.7) 
3 Was any part of the wound leaking fluid?    
 Participant self-assessments 12 (2.1) 351 (63.9) 125 (22.8) 45 (8.2) 28 (5.1) 
 Observer assessments 7 (1.2) 419 (71.0) 116 (19.7) 26 (4.4) 29 (4.9) 
3a Was it clear fluid? (serous exudate)           
 Participant self-assessments 86 (43.4) 48 (40.3) 51 (42.9) 17 (14.3) 3 (2.5) 
 Observer assessments 23 (13.5) 14 (51.6) 58 (37.4) 10 (6.5) 7 (4.5) 
3b Was it blood-stained fluid? (haemoserous exudate)           
 Participant self-assessments 47 (23.7) 45 (28.5) 77 (48.7) 24 (15.2) 12 (7.6) 
 Observer assessments 14 (8.2) 77 (46.7) 56 (33.9) 18 (10.9) 14 (8.5) 
3c Was it thick and yellow/green fluid? (pus/purulent exudate)           
 Participant self-assessments 81 (41.0) 71 (57.3) 27 (21.8) 18 (14.5) 8 (6.5) 
 Observer assessments 23 (13.5) 96 (61.9) 30 (19.4) 13 (8.4) 16 (10.3) 
4 
Have the edges of any part of the wound separated/gaped 
open on their own accord? (spontaneous dehiscence) 
  
 
 Participant self-assessments  19 (3.4) 423 (78.0) 93 (17.2) 17 (3.1) 9 (1.7) 
 Observer assessments 12 (2.0) 489 (83.6) 76 (13.0) 11 (1.9) 9 (1.5) 
4a Did the skin separate?           
 Participant self-assessments 6 (5.0) 41 (28.5) 78 (52.4) 20 (13.4) 10 (6.7) 
 Observer assessments 6 (6.3) 17 (15.6) 71 (65.1) 11 (10.1) 10 (9.2) 
4b Did the deeper tissue separate?           
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 Participant self-assessments 27 (22.7) 93 (75.6) 15 (12.2) 11 (8.9) 4 (3.3) 
 Observer assessments 16 (16.7) 77 (79.4) 10 (10.3) 4 (4.1) 6 (6.2) 
5 Has the area around the wound become swollen?           
 Participant self-assessments  14 (2.5) 345 (63.1) 160 (29.3) 35 (6.4) 7 (1.3) 
 Observer assessments 1 (0.2) 481 (80.7) 96 (16.1) 12 (2.0) 7 (1.2) 
6 Has the wound been smelly?           
 Participant self-assessments  22 (3.9) 488 (90.5) 36 (6.7) 9 (1.7) 6 (1.1) 
 Observer assessments 1 (0.2) 547 (91.8) 31 (5.2) 13 (2.2) 5 (0.8) 
7 Has the wound been painful to touch?           
 Participant self-assessments  13 (2.3) 207 (37.8) 274 (50.0) 50 (9.1) 17 (3.1) 
 Observer assessments 0 (0) 351 (58.8) 180 (30.2) 51 (8.5) 15 (2.5) 
8 
Have you had, or felt like you have had, a raised temperature 
or fever? (fever >38
o
C) 
  
 
 Participant self-assessments  20 (3.6) 462 (85.4) 57 (10.5) 11 (2.0) 11 (2.0) 
 Observer assessments 1 (0.2) 524 (87.9) 37 (6.2) 15 (2.5) 20 (3.4) 
            
    No Yes     
    n (%) n (%)     
9 
Have you sought advice because of a problem with your 
wound, other than at a routine planned follow-up appointment? 
  
 
 Participant self-assessments  4 (0.7) 396 (71.1) 161 (28.9)     
 Observer assessments 8 (1.3) 442 (75.0) 147 (25.0)     
10 
Has anything been put on the skin to cover the wound? 
(dressing) 
  
 
 Participant self-assessments  6 (1.1) 333 (60.0) 222 (40.0)     
 Observer assessments 4 (0.7) 396 (66.8) 197 (33.2)     
11 
Have you been back into hospital for treatment with a problem 
with your wound? 
  
 
 Participant self-assessments  17 (3.0) 514 (94.5) 30 (5.5)     
 Observer assessments 22 (3.7) 548 (95.3) 27 (4.7)     
            
    No Yes Don’t know   
    n (%) n (%) n (%)   
12 
Have you been given antibiotics for a problem with your 
wound? 
  
 
 Participant self-assessments  9 (1.6) 463 (83.9) 82 (14.9) 7 (1.3)   
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 Observer assessments 5 (0.8) 511 (86.3) 81 (13.7) 0 (0)   
13 
Have the edges of your wound been deliberately separated by 
a doctor or nurse? 
  
 
 Participant self-assessments  7 (1.3) 532 (96.0) 16 (2.9) 6 (1.1)   
 Observer assessments 4 (0.7) 572 (96.5) 21 (3.5) 0 (0)   
14 
Has your wound been scraped or cut to remove any unwanted 
tissue? (debridement of wound) 
  
 
 Participant self-assessments  13 (2.3) 539 (98.4) 6 (1.1) 3 (0.6)   
 Observer assessments 3 (0.5) 588 (99.0) 6 (1.0) 0 (0)   
15 Has your wound been drained? (drainage of pus/abscess)           
 Participant self-assessments  18 (3.2) 518 (95.4) 21 (3.9) 4 (0.74)   
 Observer assessments 5 (0.8) 580 (98.0) 11 (1.9) 1 (0.2)   
16 
Have you had an operation under general anaesthetic for 
treatment of a problem with your wound? 
  
 
 Participant self-assessments  15 (2.7) 542 (99.3) 2 (0.4) 2 (0.4)   
 Observer assessments 7 (1.2) 590 (100) 0 (0) 0 (0)   
 
*Percentages of missing responses were calculated as the proportion missing in an otherwise completed WHQ (n=561 and n=597, self- and observer 
assessments respectively). For questions 3a-c and 4a-b collecting additional information, percentages were calculated as the proportion missing where a 
response would have been expected (i.e. responses to items 3 and 4 that were anything other than ‘not at all’ (patient self-assessments n=198 and n=119, 
respectively; observer assessments n=171 and n=96, respectively) 
**Percentages were calculated as the proportion of available data (excluding missing responses) 
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Supplementary Table S2: Test-retest reliability in participant self-assessments (n=44) 
Item N 
% observed 
agreement 
% expected 
agreement 
Weighted 
Kappa 
% agreed 
responses 
that were 
‘Not at all’/ 
‘No’ Missing 
1 Was there redness spreading away from the wound? 
(erythema/cellulitis) 
41 86.2 80.1 0.3051 39.0 
1 (first test) 
2 (retest) 
2 Was the area around the wound warmer than the 
surrounding skin? 
38 88.6 82.5 0.3500 47.4 
2 (first test) 
5 (retest) 
3 Was any part of the wound leaking fluid? 43 92.3 73.8 0.7043 55.8 1 (retest) 
3a Was it clear fluid? (serous exudate) 
4 100 87.5 1.000 75.0 
6 (first test) 
9 (retest) 
3b Was it blood-stained fluid? (haemoserous exudate) 
11 93.9 74.1 0.7660 14.3 
2 (first test) 
3 (retest) 
3c Was it thick and yellow/green fluid (pus/purulent exudate) 
5 86.7 54.7 0.7059 14.3 
5 (first test) 
6 (retest) 
4 Have the edges of any part of the wound separated/gaped 
open on their own accord? (spontaneous dehiscence) 
43 97.7 84.4 0.8509 74.4 1 (retest) 
4a Did the skin separate? 8 100 87.5 1.00 75.0 1 (first test) 
4b Did the deeper tissue separate? 
6 100 87.5 1.00 83.3 
3 (first test) 
3 (retest) 
5 Has the area around the wound become swollen? 44 93.2 81.8 0.6250 59.1 0 
6 Has the wound been smelly? 
43 97. 7 96.4 0.3645 90.7 
1 (first test) 
1 (retest) 
7 Has the wound been painful to touch? 43 91.5 79.4 0.5854 37.2 1 (retest) 
8 Have you had, or felt like you have had, a raised temperature 
or fever? (fever >38
o
C) 
43 96.1 93.7 0.3804 83.7 1 (retest) 
9 Have you sought advice because of a problem with your 
wound, other than at a routine planned follow-up 
appointment? 
43 86.15 56.0 0.6830 60.5 1 (first test) 
10 Has anything been put on the skin to cover the wound? 
(dressing) 
44 97.7 50.6 0.9540 43.2 0 
11 Have you been back into hospital for treatment with a 
problem with your wound? 
44 100 83.5 1.000 90.9 0 
12 Have you been given antibiotics for a problem with you 
wound? 
43 95.4 75.9 0.8072 83.7 1 (retest) 
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Item N 
% observed 
agreement 
% expected 
agreement 
Weighted 
Kappa 
% agreed 
responses 
that were 
‘Not at all’/ 
‘No’ Missing 
13 Have the edges of your wound been deliberately separated 
by a doctor or nurse? 
43 97.7 97.7 0.0000 95.5 
1 don’t know 
(retest) 
14 Has your wound been scraped or cut to remove any 
unwanted tissue? (debridement of wound) 
39 94.9 95.0 -0.0263 92.5 
1 (first test) 
3 (retest) 
1 don’t know 
(retest) 
15 Has your wound been drained? (drainage of pus/abscess) 
41 100 95.2 1.000 97.6 
1 (first test) 
2 (retest) 
16
†
 Have you had an operation under general anaesthetic for 
treatment of a problem with your wound? 40 100 - - 100 
2 (first test) 
2 (retest) 
 
 
†
Expected agreement and Kappa statistic not possible to compute as all observations were of the same category (‘No’) 
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Supplementary Table S3: Self- and observer agreement, for participants with data from both assessments (n=470) 
 
Item N 
% observed 
agreement 
% 
expected 
agreement 
Weighted 
Kappa 
% agreed responses 
that were ‘Not at all’/ 
‘No’ 
1 Was there redness spreading away from the wound? 
(erythema/cellulitis) 
463 87.5 78.2 0.4260 50.3 
2 Was the area around the wound warmer than the 
surrounding skin? 
454 89.1 79.8 0.4597 54.9 
3 Was any part of the wound leaking fluid? 458 94.0 76.5 0.7432 63.3 
3a Was it clear fluid? (serous exudate) 67 90.6 71.4 0.6691 29.9 
3b Was it blood-stained fluid? (haemoserous exudate) 89 86.7 68.6 0.5784 22.5 
3c Was it thick and yellow/green fluid (pus/purulent exudate) 71 84.7 68.5 0.5143 42.3 
4 Have the edges of any part of the wound separated/gaped 
open on their own accord? (spontaneous dehiscence) 
447 95.2 86.9 0.6314 76.5 
4a) Did the skin separate? 56 88.6 74.6 0.5501 0 
4b) Did the deeper tissue separate? 43 91.0 74.7 0.6456 62.8 
5 Has the area around the wound become swollen? 459 88.2 82.9 0.3092 59.0 
6 Has the wound been smelly? 454 97.4 93.7 0.5911 89.9 
7 Has the wound been painful to touch? 462 84.3 75.0 0.3748 31.6 
8 Have you had, or felt like you have had, a raised 
temperature or fever? (fever >38
o
C) 
454 94.9 89.4 0.5203 83.5 
9 Have you sought advice because of a problem with your 
wound, other than at a routine planned follow-up 
appointment? 
461 85.9 61.8 0.6312 67.3 
10 Has anything been put on the skin to cover the wound? 
(dressing) 
464 84.7 53.3 0.6721 55.4 
11 Have you been back into hospital for treatment with a 
problem with your wound? 
437 95.7 91.1 0.5138 93.1 
12 Have you been given antibiotics for a problem with you 
wound? 
454 96.3 76.9 0.8379 83.3 
13 Have the edges of your wound been deliberately 
separated by a doctor or nurse? 
456 96.9 93.6 0.5175 94.1 
14 Has your wound been scraped or cut to remove any 
unwanted tissue? (debridement of wound) 
454 98.7 97.8 0.3936 97.8 
15 Has your wound been drained? (drainage of pus/abscess) 445 97.1 94.9 0.4221 95.1 
16 Have you had an operation under general anaesthetic for 
treatment of a problem with your wound? 
449 99.8 99.8 0.0000 99.3 
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Supplementary Table S4.  Cross-tabulation of self-assessment WHQ total score and face-to-face reference SSI diagnoses  
 
 Self-assessment WHQ total score 
 0 1 2 3 4 5 6 7 8 9 10 11 12 13 15 17 18 19 20 26 28 30 Total 
Reference diagnosis                        
No SSI 43 43 20 31 14 6 6 2 7 2 0 1 0 1 0 0 0 0 0 0 0 0 176 
SSI of any type 2 0 1 0 1 3 0 2 1 1 2 2 2 2 4 3 1 1 1 1 1 1 32 
Total 45 43 21 31 15 9 6 4 8 3 2 3 2 3 4 3 1 1 1 1 1 1 208 
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Supplementary Table S5. Sensitivity and specificity of selected self-assessment 
WHQ total score cut-off thresholds compared to the reference SSI diagnosis  
 
WHQ self-
assessment score  
cut-off threshold 
Sensitivity 
(%) 
Specificity 
(%) 
5 87.5 85.8 
6 78.1 89.2 
7 78.1 92.6 
8 71.9 93.8 
9 68.8 97.7 
10 65.6 98.9 
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